|
⚲
|
| Keyboard |
| Agger Mette Kirstine
✚
|
|
|---|---|
| CIK # | 0001722234 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001722234] | |
| 4 | [0001722234] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Agger Mette Kirstine | |
| Lexeo Therapeutics Inc | |
| scPharmaceuticals Inc | |
| Enliven Therapeutics Inc | |
| Trevi Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
scPharmaceuticals Inc SCPH
Stock Option (Right to Buy) · derivative
|
2025-10-07 | Disposed to issuer | 30,000 | $0.00 | |
|
scPharmaceuticals Inc SCPH
Stock Option (Right to Buy) · derivative
|
2025-10-07 | Disposed to issuer | 19,750 | $0.00 | |
|
Lexeo Therapeutics Inc LXEO
Stock Option (right to buy) · derivative
|
2025-06-26 | Grant | 25,000 | $0.00 | |
|
scPharmaceuticals Inc SCPH
Stock Option (Right to Buy) · derivative
|
2025-06-03 | Grant | 30,000 | $0.00 | |
|
Lexeo Therapeutics Inc LXEO
Stock Option (right to buy) · derivative
|
2024-06-25 | Grant | 18,000 | $0.00 | |
|
scPharmaceuticals Inc SCPH
Stock Option (Right to Buy) · derivative
|
2024-06-11 | Grant | 19,750 | $0.00 | |
|
Lexeo Therapeutics Inc LXEO
Stock Option (right to buy) · derivative
|
2024-02-02 | Grant | 36,000 | $0.00 | |
|
scPharmaceuticals Inc SCPH
Stock Option (Right to Buy) · derivative
|
2023-06-06 | Grant | 17,300 | $0.00 | |
|
scPharmaceuticals Inc SCPH
Stock Option (Right to Buy) · derivative
|
2020-06-09 | Grant | 6,124 | $0.00 | |
|
Enliven Therapeutics Inc IMRA
Series A Preferred Stock · derivative
|
2020-03-16 | Conversion | 5,470,492 | $0.00 | |
|
Enliven Therapeutics Inc IMRA
Common Stock
|
2020-03-16 | Conversion | 1,245,222 | ||
|
Enliven Therapeutics Inc IMRA
Common Stock
|
2020-03-16 | Buy | 187,500 | $16.00 | 3,000,000 |
|
Enliven Therapeutics Inc IMRA
Series B Preferred Stock · derivative
|
2020-03-16 | Conversion | 1,894,444 | $0.00 | |
|
Enliven Therapeutics Inc IMRA
Stock Option (right to buy) · derivative
|
2020-03-16 | Grant | 15,457 | $0.00 | |
|
Enliven Therapeutics Inc IMRA
Series Seed Preferred Stock · derivative
|
2020-03-16 | Conversion | 478,749 | $0.00 | |
|
scPharmaceuticals Inc SCPH
Stock Option (Right to Buy) · derivative
|
2019-06-18 | Grant | 6,124 | $0.00 | |
|
Trevi Therapeutics Inc TRVI
Series C Preferred Stock · derivative
|
2019-05-09 | Conversion | 6,849,315 | $0.00 | |
|
Trevi Therapeutics Inc TRVI
Common Stock
|
2019-05-09 | Conversion | 776,544 | ||
|
Trevi Therapeutics Inc TRVI
Common Stock
|
2019-05-09 | Buy | 375,000 | $10.00 | 3,750,000 |
|
Trevi Therapeutics Inc TRVI
Stock Option (right to buy) · derivative
|
2019-05-07 | Grant | 23,684 | $0.00 | |
| showing 20 of 25 most recent transactions | |||||